0,890  0,002  Cocaine dependence treatment
0,890  0,005  Analgesic
0,889  0,004  CYP2D6 substrate
0,844  0,001  NMDA receptor phencyclidine site antagonist
0,843  0,002  UGT2B1 substrate
0,840  0,002  UGT1A1 substrate
0,798  0,002  NMDA 2C receptor antagonist
0,791  0,006  Respiratory analeptic
0,785  0,002  Opioid antagonist
0,776  0,002  Analgesic, opioid
0,765  0,003  UGT1A3 substrate
0,761  0,002  Sigma receptor agonist
0,759  0,005  Antiparkinsonian
0,751  0,002  Opioid agonist
0,745  0,002  Opioid mu receptor antagonist
0,748  0,009  CYP2C9 substrate
0,723  0,002  Opioid delta receptor antagonist
0,724  0,005  Dependence treatment
0,720  0,006  5 Hydroxytryptamine release stimulant
0,695  0,000  Narcotic antagonist
0,686  0,002  Opioid mu receptor agonist
0,679  0,002  Opioid kappa receptor antagonist
0,686  0,008  Analeptic
0,677  0,009  CYP2C19 substrate
0,671  0,004  Muscle relaxant
0,674  0,020  CYP3A4 substrate
0,655  0,003  NMDA receptor antagonist
0,653  0,003  NMDA 2 receptor antagonist
0,653  0,005  Sedative
0,651  0,009  Spasmolytic
0,622  0,004  Sigma receptor antagonist
0,615  0,003  Opioid delta receptor agonist
0,614  0,003  Dopamine D1 antagonist
0,594  0,001  UGT2B9 substrate
0,594  0,002  UGT2B7 substrate
0,596  0,014  Stroke treatment
0,582  0,008  CYP2D6 inhibitor
0,543  0,004  Alpha 2a adrenoreceptor antagonist
0,536  0,004  Dopamine D2 agonist
0,529  0,004  Antitussive
0,540  0,019  CYP1A2 substrate
0,522  0,004  Dopamine agonist
0,526  0,012  Antineurogenic pain
0,520  0,010  Huntington's disease treatment
0,513  0,006  Anesthetic
0,503  0,004  Antismoking
0,532  0,040  Transcription factor NF kappa B inhibitor
0,496  0,005  Antialcoholic
0,499  0,010  Amyotrophic lateral sclerosis treatment
0,483  0,002  Opioid kappa receptor agonist
0,496  0,015  Cardiodepressant
0,478  0,001  Prolactin inhibitor
0,468  0,005  Cholinergic antagonist
0,467  0,005  Acetylcholine antagonist
0,462  0,006  Dopamine antagonist
0,467  0,013  Acute neurologic disorders treatment
0,456  0,004  Nav1.1 sodium channel blocker
0,456  0,004  Alpha 2 adrenoreceptor antagonist
0,445  0,002  Toll-Like receptor 4 antagonist
0,446  0,006  Dopamine D2 antagonist
0,466  0,033  Antidepressant
0,438  0,005  Acetylcholine M1 receptor antagonist
0,437  0,004  Acetylcholine nicotinic antagonist
0,432  0,004  Toll-Like receptor antagonist
0,442  0,016  UDP-glucuronosyltransferase substrate
0,420  0,004  Constipation treatment
0,416  0,005  CNS active muscle relaxant
0,431  0,040  Teratogen
0,431  0,044  Mood disorders treatment
0,388  0,005  Alpha 2b adrenoreceptor antagonist
0,383  0,007  Antipruritic
0,381  0,007  Toxic, respiratory center
0,381  0,009  Antidote
0,392  0,024  Psychostimulant
0,383  0,019  Anesthetic general
0,360  0,009  Antidiarrheal
0,386  0,044  Embryotoxic
0,341  0,004  NMDA 2A receptor antagonist
0,348  0,012  Alpha adrenoreceptor antagonist
0,337  0,004  Dopamine uptake inhibitor
0,333  0,004  Dopamine D5 antagonist
0,391  0,067  CYP2C19 inhibitor
0,362  0,041  Hypoxia-inducible factor 1 alpha inhibitor
0,337  0,017  Antipruritic, non-allergic
0,360  0,040  Sensitization
0,416  0,102  Caspase 9 stimulant
0,317  0,003  NMDA receptor subunit 3B antagonist
0,323  0,015  Antiischemic, cerebral
0,312  0,005  Dopamine D3 antagonist
0,377  0,073  Immunosuppressant
0,301  0,006  Alpha 2c adrenoreceptor antagonist
0,377  0,087  TNF expression inhibitor
0,293  0,005  Neuronal nicotinic receptor antagonist
0,321  0,035  Anticonvulsant
0,295  0,009  Acetylcholine muscarinic antagonist
0,344  0,059  AR expression inhibitor
0,306  0,022  Contraceptive
0,328  0,044  Cardiovascular analeptic
0,288  0,006  Nav1.6 sodium channel blocker
0,287  0,016  Nav1.2 sodium channel blocker
0,405  0,137  Antiinflammatory
0,327  0,060  Cardioprotectant
0,288  0,020  Cholinergic
0,324  0,062  Antiepileptic
0,324  0,064  CYP3A4 inhibitor
0,275  0,025  Skeletal muscle relaxant
0,335  0,085  Cognition disorders treatment
0,307  0,058  UGT2B4 substrate
0,314  0,066  Antipsychotic
0,259  0,014  Neuropathy treatment
0,260  0,018  Anesthetic local
0,261  0,021  Interleukin 6 antagonist
0,243  0,004  NMDA receptor subunit 3A antagonist
0,281  0,043  Tyrosine 3 hydroxylase inhibitor
0,251  0,014  Nav1.3 sodium channel blocker
0,333  0,100  Antipruritic, allergic
0,274  0,046  Nitric oxide antagonist
0,231  0,004  Antiprotozoal activity enhancer
0,301  0,075  Antineoplastic (endocrine cancer)
0,218  0,003  Sigma 2 receptor antagonist
0,248  0,041  Pneumotoxic
0,282  0,084  NOS3 expression inhibitor
0,263  0,069  Hypoglycemic
0,199  0,005  Acetylcholine M3 receptor agonist
0,202  0,014  Acetylcholine agonist
0,256  0,069  5 Hydroxytryptamine 1E antagonist
0,213  0,029  Acetylcholinesterase inhibitor
0,197  0,013  Estrogen antagonist
0,179  0,002  Prolactin release inhibitor
0,209  0,037  NOS3 expression enhancer
0,189  0,019  Retinopathy treatment
0,196  0,027  Glutamate receptor antagonist
0,195  0,027  5 Hydroxytryptamine 2B antagonist
0,247  0,080  Antihypercholesterolemic
0,201  0,036  UGT2B10 substrate
0,275  0,110  Vasodilator, peripheral
0,205  0,041  UGT2B15 substrate
0,255  0,097  FMO3 substrate
0,185  0,027  Antiadrenergic
0,180  0,024  Alpha 1 adrenoreceptor antagonist
0,174  0,020  Alpha 1a adrenoreceptor antagonist
0,159  0,005  Sigma 1 receptor antagonist
0,179  0,028  Adrenaline antagonist
0,256  0,107  Caspase 3 stimulant
0,275  0,128  Antineoplastic (non-Hodgkin's lymphoma)
0,251  0,109  Prostate cancer treatment
0,156  0,014  Estrogen receptor beta antagonist
0,166  0,024  Contraceptive female
0,308  0,167  Apoptosis agonist
0,240  0,100  Immunostimulant
0,151  0,012  Postmenopausal disorders treatment
0,145  0,010  Adrenaline uptake inhibitor
0,160  0,025  Antineoplastic alkaloid
0,193  0,061  LDLR expression enhancer
0,270  0,139  Antiobesity
0,162  0,038  Adenylate cyclase inhibitor
0,218  0,095  Antipyretic
0,127  0,005  Nociceptin (N/OFQ) receptor antagonist
0,223  0,102  UGT1A9 substrate
0,135  0,014  Alpha 2d adrenoreceptor antagonist
0,178  0,060  Prostate disorders treatment
0,136  0,019  Alpha adrenoreceptor agonist
0,193  0,076  Abortion inducer
0,182  0,067  UGT1A4 substrate
0,119  0,005  Nicotinic receptor beta4 subunit antagonist
0,131  0,019  5 Hydroxytryptamine uptake inhibitor
0,208  0,096  NOS2 expression inhibitor
0,208  0,096  Antihypotensive
0,128  0,019  Restless leg syndrome treatment
0,158  0,051  Adenylate cyclase stimulant
0,122  0,018  Estrogen receptor alpha antagonist
0,209  0,108  Antioxidant
0,180  0,081  Sleep disorders treatment
0,166  0,067  Uterine stimulant
0,118  0,024  Tocolytic
0,099  0,007  Acetylcholine M2 receptor agonist
0,107  0,016  Estrogen agonist
0,112  0,022  Nicotinic alpha4beta2 receptor antagonist
0,119  0,029  Alpha 1b adrenoreceptor antagonist
0,118  0,031  SULT1E1 substrate
0,121  0,034  UGT2B11 substrate
0,156  0,069  Insulin secretagoues
0,206  0,119  Radioprotector
0,104  0,018  CC chemokine 5 receptor agonist
0,146  0,062  Calcium channel blocker
0,230  0,150  Sodium/bile acid cotransporter inhibitor
0,089  0,009  Postcoital contraceptive
0,109  0,029  5 Hydroxytryptamine 1A antagonist
0,159  0,079  Chemopreventive
0,097  0,018  Acetylcholine muscarinic agonist
0,153  0,075  Diuretic
0,100  0,023  Alpha 1d adrenoreceptor antagonist
0,210  0,133  5 Hydroxytryptamine uptake stimulant
0,201  0,125  Antiosteoporotic
0,100  0,025  Calcium channel L-type blocker
0,097  0,023  Glycine receptor agonist
0,128  0,055  Menstruation disorders treatment
0,203  0,131  Chemoprotective
0,074  0,004  Dopamine D1 agonist
0,079  0,012  Oxytocin antagonist
0,147  0,081  Interferon gamma antagonist
0,067  0,003  Vesicular acetylcholine transporter inhibitor
0,111  0,049  Anabolic
0,084  0,021  Alpha 2 adrenoreceptor agonist
0,076  0,015  Estrogen receptor beta agonist
0,103  0,043  5 Hydroxytryptamine 2C antagonist
0,170  0,110  Neurotrophic factor enhancer
0,077  0,018  Dopamine transporter inhibitor
0,174  0,116  Antiglaucomic
0,091  0,032  SULT1A2 substrate
0,206  0,148  Bone diseases treatment
0,229  0,174  GABA C receptor rho-3 antagonist
0,145  0,091  Prostatic (benign) hyperplasia treatment
0,133  0,080  Antiparkinsonian, tremor relieving
0,109  0,058  Antiinfertility, female
0,132  0,082  Lipid peroxidase inhibitor
0,078  0,028  Uterine relaxant
0,134  0,084  Antimutagenic
0,154  0,106  Hepatoprotectant
0,067  0,020  11-Beta-hydroxysteroid dehydrogenase 1 inhibitor
0,191  0,144  Flavin-containing monooxygenase substrate
0,072  0,024  NMDA 2B receptor antagonist
0,056  0,010  5 Hydroxytryptamine 2B agonist
0,163  0,117  HERG channel blocker
0,134  0,089  Antiviral (Influenza A)
0,073  0,028  Androgen agonist
0,113  0,069  5 Hydroxytryptamine antagonist
0,093  0,049  Contraceptive male
0,055  0,012  Alpha 1L adrenoreceptor agonist
0,075  0,032  SULT2A1 substrate
0,086  0,043  5 Hydroxytryptamine 1 antagonist
0,073  0,031  Narcolepsy treatment
0,048  0,007  Vasopressin 1B antagonist
0,173  0,132  Tumour necrosis factor alpha release inhibitor
0,163  0,123  Antiparkinsonian, rigidity relieving
0,101  0,062  Chronic obstructive bronchitis treatment
0,168  0,129  UGT1A6 substrate
0,170  0,131  Vasodilator
0,052  0,013  Vasopressin 2 antagonist
0,067  0,029  Alpha 1 adrenoreceptor agonist
0,164  0,126  Potassium channel (Voltage-sensitive) blocker
0,190  0,154  Antihypoxic
0,131  0,096  Antifungal (Cryptococcus)
0,051  0,017  Dopamine D5 agonist
0,070  0,036  Acetylcholine M2 receptor antagonist
0,172  0,137  Myocardial infarction treatment
0,150  0,117  P-glycoprotein inhibitor
0,051  0,017  Estrogen receptor alpha agonist
0,112  0,080  Alcohol dehydrogenase substrate
0,050  0,019  Dopamine D3 agonist
0,058  0,031  Nicotinic receptor alpha7 subunit antagonist
0,126  0,099  Genotoxic
0,041  0,014  Acetylcholine M4 receptor agonist
0,050  0,025  Acetylcholine M1 receptor agonist
0,064  0,039  5 Hydroxytryptamine 5A antagonist
0,107  0,082  Interleukin 8 antagonist
0,093  0,069  Antiemetic
0,116  0,094  Antifungal enhancer
0,064  0,042  5 Hydroxytryptamine 3 agonist
0,095  0,075  5 Hydroxytryptamine 2 antagonist
0,131  0,112  Melanin inhibitor
0,054  0,036  Nicotinic alpha3beta2 receptor antagonist
0,059  0,042  Acetylcholine M3 receptor antagonist
0,071  0,058  Cushing's syndrome treatment
0,065  0,052  Premenstrual syndrome treatment
0,045  0,033  Adenylate cyclase 1 inhibitor
0,030  0,019  Vasopressin 1A antagonist
0,158  0,147  Cytostatic
0,083  0,074  HIV-1 integrase (Overall Integration) inhibitor
0,058  0,049  5 Hydroxytryptamine 2A agonist
0,136  0,128  Lipocortins synthesis antagonist
0,024  0,016  Dopamine autoreceptor agonist
0,183  0,176  Antineoplastic (lung cancer)
0,172  0,166  Anxiolytic
0,107  0,101  Toll-Like receptor 9 antagonist
0,157  0,151  VEGF expression inhibitor
0,086  0,081  Glutathione S-transferase substrate
0,030  0,025  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,122  0,118  Growth hormone agonist
0,033  0,029  5 Hydroxytryptamine 3B antagonist
0,031  0,027  Estrogen-related receptor beta antagonist
0,053  0,050  5 Hydroxytryptamine 5 antagonist
0,123  0,122  Arachidonic acid antagonist
0,028  0,027  Vasopressin 1 antagonist
0,057  0,057  Heme oxygenase stimulant

